The dietary antioxidant piceatannol inhibits adipogenesis of human adipose mesenchymal stem cells and limits glucose transport and lipogenic activities in adipocytes

International Journal of Molecular Sciences

Volumn 19, Issue 7, 2018, Pages

  Carpéné, Christian ^a   Pejenaute, Héctor ^b   Del Moral, Raquel ^b   Boulet, Nathalie ^a   Hijona, Elizabeth ^c   Andrade, Fernando ^d   Villanueva Millán, Maria Jesùs ^e   Aguirre, Leixuri ^c,f   Arbones Mainar, José Miguel ^b,f  

^a Université de Toulouse   (France)

^b INSTITUTO DE INVESTIGACIÓN SANITARIA ARAGÓN IIS ARAGÓN   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d BIOCRUCES BIZKAIA HEALTH RESEARCH INSTITUTE   (Spain)

^e CENTER FOR BIOMEDICAL RESEARCH OF LA RIOJA CIBIR   (Spain)

^f Instituto de Salud Carlos III   (Spain)

Author keywords

Adipogenesis; Fat cells; Hydrogen peroxide; Resveratrol; Stilbenoids

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN; PICEATANNOL; RESVERATROL; 3,3',4,5'-TETRAHYDROXYSTILBENE; ANTIOXIDANT; GLUCOSE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STILBENE DERIVATIVE; TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 6;

ABDOMINAL SUBCUTANEOUS FAT; ADIPOCYTE; ADIPOGENESIS; ADIPOSE DERIVED STEM CELL; ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY MASS; CELL DIFFERENTIATION; CELL MATURATION; CELL VIABILITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; LIPID STORAGE; LIPOGENESIS; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; OBESITY; PROADIPOCYTE; QUANTITATIVE ANALYSIS; SCANNING ELECTRON MICROSCOPY; TISSUE HOMOGENATE; 3T3-L1 CELL LINE; ADIPOSE TISSUE; ANIMAL; CELL CULTURE; CYTOLOGY; DIETARY SUPPLEMENT; DRUG EFFECT; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ADIPOSE TISSUE; ADULT; ANIMALS; ANTIOXIDANTS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; DIETARY SUPPLEMENTS; FAS RECEPTOR; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HUMANS; LIPOGENESIS; MESENCHYMAL STROMAL CELLS; MICE; PPAR GAMMA; STILBENES;

EID: 85050356150     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms19072081     Document Type: Article

References (37)

1. Lagouge, M.; Argmann, C.; Gerhart-Hines, Z.; Meziane, H.; Lerin, C.; Daussin, F.; Messadeq, N.; Milne, J.; Lambert, P.; Elliott, P.; et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 2006, 127, 1109–1122.
2. Fernandez-Quintela, A.; Carpéné, C.; Fernandez, M.; Aguirre, L.; Milton-Laskibar, I.; Contreras, J.; Portillo, M.P. Anti-obesity effects of resveratrol: Comparison between animal models and humans. J. Physiol. Biochem. 2016, 73, 417–429.
3. Liu, K.; Zhou, R.; Wang, B.; Mi, M.T. Effect of resveratrol on glucose control and insulin sensitivity: A meta-analysis of 11 randomized controlled trials. Am. J. Clin. Nutr. 2014, 99, 1510–1519.
4. Christenson, J.; Whitby, S.J.; Mellor, D.; Thomas, J.; McKune, A.; Roach, P.D.; Naumovski, N. The Effects of Resveratrol Supplementation in Overweight and Obese Humans: A Systematic Review of Randomized Trials. Metab. Syndr. Relat. Disord. 2016, 14, 323–333.
5. Visioli, F. The resveratrol fiasco. Pharmacol. Res. 2014, 90, 87, doi:10.1016/j.phrs.2014.08.003.
6. Carpéné, C.; Gomez-Zorita, S.; Deleruyelle, S.; Carpéné, M.A. Novel strategies for preventing diabetes and obesity complications with natural polyphenols. Curr. Med. Chem. 2015, 22, 150–164.
7. Kershaw, J.; Kim, K.H. The Therapeutic Potential of Piceatannol, a Natural Stilbene, in Metabolic Diseases: A Review. J. Med. Food 2017, 20, 427–438.
8. Piotrowska, H.; Kucinska, M.; Murias, M. Biological activity of piceatannol: Leaving the shadow of resveratrol. Mutat. Res. 2012, 750, 60–82.
9. Tang, Y.L.; Chan, S.W. A review of the pharmacological effects of piceatannol on cardiovascular diseases. Phytother. Res. 2014, 28, 1581–1588.
10. Kwon, J.Y.; Seo, S.G.; Heo, Y.S.; Yue, S.; Cheng, J.X.; Lee, K.W.; Kim, K.H. Piceatannol, natural polyphenolic stilbene, inhibits adipogenesis via modulation of mitotic clonal expansion and insulin receptor-dependent insulin signaling in early phase of differentiation. J. Biol. Chem. 2012, 287, 11566–11578.
11. Hijona, E.; Aguirre, L.; Perez-Matute, P.; Villanueva-Millan, M.J.; Mosqueda-Solis, A.; Hasnaoui, M.; Nepveu, F.; Senard, J.M.; Bujanda, L.; Aldamiz-Echevarria, L.; et al. Limited beneficial effects of piceatannol supplementation on obesity complications in the obese Zucker rat: Gut microbiota, metabolic, endocrine, and cardiac aspects. J. Physiol. Biochem. 2016, 72, 567–582.
12. Mosqueda-Solis, A.; Lasa, A.; Gomez-Zorita, S.; Eseberri, I.; Pico, C.; Portillo, M.P. Screening of potential anti-adipogenic effects of phenolic compounds showing different chemical structure in 3T3-L1 preadipocytes. Food Funct. 2017, 8, 3576–3586.
13. Huang, X.; Ordemann, J.; Muller, J.M.; Dubiel, W. The COP9 signalosome, cullin 3 and Keap1 supercomplex regulates CHOP stability and adipogenesis. Biol. Open 2012, 1, 705–710.
14. van Beek, E.A.; Bakker, A.H.; Kruyt, P.M.; Vink, C.; Saris, W.H.; Franssen-van Hal, N.L.; Keijer, J. Comparative expression analysis of isolated human adipocytes and the human adipose cell lines LiSa-2 and PAZ6. Int. J. Obes. (Lond.) 2008, 32, 912–921.
15. Green, H.; Kehinde, O. An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 1975, 5, 19–27.
16. Krieger-Brauer, H.I.; Medda, P.K.; Kather, H. Insulin-induced activation of NADPH-dependent H2O2 generation in human adipocyte plasma membranes is mediated by Galphai2. J. Biol. Chem. 1997, 272, 10135– 10143.
17. Green, A.; Bustillos, D.P.; Misbin, R.I. β-Hydroxybutyrate increases the insulin sensitivity of adipocyte glucose transport at a postreceptor level. Diabetes 1984, 33, 1045–1050.
18. Morin, N.; Lizcano, J.M.; Fontana, E.; Marti, L.; Smih, F.; Rouet, P.; Prévot, D.; Zorzano, A.; Unzeta, M.; Carpéné, C. Semicarbazide-sensitive amine oxidase substrates stimulate glucose transport and inhibit lipolysis in human adipocytes. J. Pharmacol. Exp. Ther. 2001, 297, 563–572.
19. Gomez-Zorita, S.; Belles, C.; Briot, A.; Fernandez-Quintela, A.; Portillo, M.P.; Carpéné, C. Pterostilbene Inhibits Lipogenic Activity similar to Resveratrol or Caffeine but Differently Modulates Lipolysis in Adipocytes. Phytother. Res. 2017, 31, 1273–1282.
20. Setoguchi, Y.; Oritani, Y.; Ito, R.; Inagaki, H.; Maruki-Uchida, H.; Ichiyanagi, T.; Ito, T. Absorption and metabolism of piceatannol in rats. J. Agric. Food Chem. 2014, 62, 2541–2548.
21. Kitada, M.; Ogura, Y.; Maruki-Uchida, H.; Sai, M.; Suzuki, T.; Kanasaki, K.; Hara, Y.; Seto, H.; Kuroshima, Y.; Monno, I.; et al. The Effect of Piceatannol from Passion Fruit (Passiflora edulis) Seeds on Metabolic Health in Humans. Nutrients 2017, 9, 1142, doi:10.3390/nu9101142.
22. Li, Y.; Yang, P.; Chang, Q.; Wang, J.; Liu, J.; Lv, Y.; Wang, T.T.Y.; Gao, B.; Zhang, Y.; Yu, L.L. Inhibitory Effect of Piceatannol on TNF-alpha-Mediated Inflammation and Insulin Resistance in 3T3-L1 Adipocytes. J. Agric. Food Chem. 2017, 65, 4634–4641.
23. Li, S.; Bouzar, C.; Cottet-Rousselle, C.; Zagotta, I.; Lamarche, F.; Wabitsch, M.; Tokarska-Schlattner, M.; Fischer-Posovszky, P.; Schlattner, U.; Rousseau, D. Resveratrol inhibits lipogenesis of 3T3-L1 and SGBS cells by inhibition of insulin signaling and mitochondrial mass increase. Biochim. Biophys. Acta 2016, 1857, 643–652.
24. Gerszon, J.; Serafin, E.; Buczkowski, A.; Michlewska, S.; Bielnicki, J.A.; Rodacka, A. Functional consequences of piceatannol binding to glyceraldehyde-3-phosphate dehydrogenase. PLoS ONE 2018, 13, e0190656, doi:10.1371/journal.pone.0190656.
25. Sueishi, Y.; Nii, R.; Kakizaki, N. Resveratrol analogues like piceatannol are potent antioxidants as quantitatively demonstrated through the high scavenging ability against reactive oxygen species and methyl radical. Bioorg. Med. Chem. Lett. 2017, 27, 5203–5206.
26. Roupe, K.A.; Yanez, J.A.; Teng, X.W.; Davies, N.M. Pharmacokinetics of selected stilbenes: Rhapontigenin, piceatannol and pinosylvin in rats. J. Pharm. Pharmacol. 2006, 58, 1443–1450.
27. Les, F.; Deleruyelle, S.; Cassagnes, L.E.; Boutin, J.A.; Balogh, B.; Arbones-Mainar, J.M.; Biron, S.; Marceau, P.; Richard, D.; Nepveu, F.; et al. Piceatannol and resveratrol share inhibitory effects on hydrogen peroxide release, monoamine oxidase and lipogenic activities in adipose tissue, but differ in their antilipolytic properties. Chem. Biol. Interact. 2016, 258, 115–125.
28. Pizzinat, N.; Marti, L.; Remaury, A.; Leger, F.; Langin, D.; Lafontan, M.; Carpéné, C.; Parini, A. High expression of monoamine oxidases in human white adipose tissue: Evidence for their involvement in noradrenaline clearance. Biochem. Pharmacol. 1999, 58, 1735–1742.
29. Wabitsch, M.; Bruderlein, S.; Melzner, I.; Braun, M.; Mechtersheimer, G.; Moller, P. LiSa-2, a novel human liposarcoma cell line with a high capacity for terminal adipose differentiation. Int. J. Cancer 2000, 88, 889– 894.
30. Shen, P.; Yue, Y.; Kim, K.H.; Park, Y. Piceatannol Reduces Fat Accumulation in Caenorhabditis elegans. J. Med. Food 2017, 20, 887–894.
31. Tung, Y.-C.; Lin, Y.-H.; Chen, H.-J.; Chou, S.-C.; Cheng, A.-C.; Kalyanam, N.; Ho, C.-T.; Pan, M.-H. Piceatannol exerts anti-obesity effects in C57BL/6 mice through modulating adipogenic proteins and gut microbiota. Molecules 2016, 21, 1419, doi:10.3390/molecules21111419.
32. Ishihata, A.; Maruki-Uchida, H.; Gotoh, N.; Kanno, S.; Aso, Y.; Togashi, S.; Sai, M.; Ito, T.; Katano, Y. Vascular-and hepato-protective effects of passion fruit seed extract containing piceatannol in chronic high-fat diet-fed rats. Food Funct. 2016, 7, 4075–4081.
33. Perez-Diaz, S.; Garcia-Rodriguez, B.; Gonzalez-Irazabal, Y.; Valero, M.; Lagos-Lizan, J.; Arbones-Mainar, J.M. Knockdown of PTRF ameliorates adipocyte differentiation and functionality of human mesenchymal stem cells. Am. J. Physiol. Cell Physiol. 2017, 312, C83–C91.
34. Gomez-Zorita, S.; Lasa, A.; Abendano, N.; Fernandez-Quintela, A.; Mosqueda-Solis, A.; Garcia-Sobreviela, M.P.; Arbones-Mainar, J.M.; Portillo, M.P. Phenolic compounds apigenin, hesperidin and kaempferol reduce in vitro lipid accumulation in human adipocytes. J. Transl. Med. 2017, 15, 237, doi:10.1186/s12967-017-1343-0.
35. Les, F.; Carpéné, C.; Arbones-Mainar, J.M.; Decaunes, P.; Valero, M.S.; Lopez, V. Pomegranate juice and its main polyphenols exhibit direct effects on amine oxidases from human adipose tissue and inhibit lipid metabolism in adipocytes. J. Funct. Foods 2017, 33, 323–331.
36. Carpéné, C.; Mercader, J.; Le Gonidec, S.; Schaak, S.; Mialet-Perez, J.; Zakaroff-Girard, A.; Galitzky, J. Body fat reduction without cardiovascular changes in mice after oral treatment by the MAO inhibitor phenelzine. Br. J. Pharmacol. 2018, 175, 2428–2440.
37. Zhou, M.; Panchuk-Voloshina, N. A one-step fluorometric method for the continuous measurement of monoamine oxidase activity. Anal. Biochem. 1997, 253, 169–174.